PEROSA, FEDERICO
 Distribuzione geografica
Continente #
NA - Nord America 3.559
EU - Europa 2.255
AS - Asia 1.529
SA - Sud America 183
Continente sconosciuto - Info sul continente non disponibili 75
AF - Africa 22
OC - Oceania 2
Totale 7.625
Nazione #
US - Stati Uniti d'America 3.496
CN - Cina 677
IE - Irlanda 544
SG - Singapore 433
UA - Ucraina 422
IT - Italia 365
RU - Federazione Russa 295
SE - Svezia 222
BR - Brasile 158
HK - Hong Kong 147
FR - Francia 132
TR - Turchia 101
FI - Finlandia 93
VN - Vietnam 69
GB - Regno Unito 61
DE - Germania 56
IN - India 43
CA - Canada 23
BD - Bangladesh 17
PL - Polonia 14
BE - Belgio 12
CZ - Repubblica Ceca 11
AR - Argentina 10
IQ - Iraq 10
ZA - Sudafrica 10
MX - Messico 8
NL - Olanda 8
SA - Arabia Saudita 8
GT - Guatemala 7
CR - Costa Rica 6
CO - Colombia 5
PR - Porto Rico 5
ES - Italia 4
HN - Honduras 4
CL - Cile 3
CW - ???statistics.table.value.countryCode.CW??? 3
EU - Europa 3
ID - Indonesia 3
IR - Iran 3
JO - Giordania 3
LT - Lituania 3
MA - Marocco 3
SI - Slovenia 3
TN - Tunisia 3
UZ - Uzbekistan 3
AT - Austria 2
AU - Australia 2
BB - Barbados 2
DZ - Algeria 2
EC - Ecuador 2
EG - Egitto 2
LB - Libano 2
MY - Malesia 2
PA - Panama 2
PE - Perù 2
SV - El Salvador 2
A1 - Anonimo 1
AE - Emirati Arabi Uniti 1
AM - Armenia 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
CH - Svizzera 1
DM - Dominica 1
HU - Ungheria 1
JM - Giamaica 1
JP - Giappone 1
LK - Sri Lanka 1
MC - Monaco 1
NG - Nigeria 1
NI - Nicaragua 1
OM - Oman 1
PS - Palestinian Territory 1
PT - Portogallo 1
PY - Paraguay 1
RO - Romania 1
RS - Serbia 1
SN - Senegal 1
SY - Repubblica araba siriana 1
TT - Trinidad e Tobago 1
UY - Uruguay 1
VE - Venezuela 1
Totale 7.557
Città #
Dublin 544
San Jose 457
Chandler 386
Dallas 304
Dearborn 302
Jacksonville 294
Singapore 179
Ashburn 160
Nanjing 158
Hong Kong 147
Beijing 137
Nyköping 109
Council Bluffs 90
Santa Clara 80
Nanchang 67
Columbus 66
Princeton 63
Lauterbourg 62
San Mateo 56
Moscow 49
Wilmington 49
The Dalles 43
Alexandria 40
Helsinki 36
Ann Arbor 33
Kunming 33
Shenyang 33
Boardman 32
Tianjin 30
New York 29
Rome 29
Munich 25
Ho Chi Minh City 23
Jiaxing 23
Los Angeles 20
Milan 20
Changsha 16
Des Moines 15
Hanoi 15
Hebei 15
São Paulo 15
Woodbridge 14
Hangzhou 13
Phoenix 13
Brussels 12
Seattle 12
Brno 11
Changchun 10
Bari 9
Chennai 9
Chicago 9
Florence 9
Hilden 9
Jinan 9
Ningbo 9
Orem 9
Bologna 8
Lanzhou 8
London 8
Atlanta 7
Napoli 7
Radomsko 7
Shanghai 7
Zhengzhou 7
Amsterdam 6
Catania 6
Guangzhou 6
Newark 6
Norwalk 6
Rio de Janeiro 6
San Francisco 6
Hefei 5
Nuremberg 5
Ottawa 5
Riyadh 5
Taizhou 5
Toronto 5
Washington 5
Auburn Hills 4
Brooklyn 4
Catanzaro 4
Da Nang 4
Denver 4
Frankfurt am Main 4
Johannesburg 4
Livorno 4
Manchester 4
Naples 4
New Delhi 4
North Bergen 4
Peccioli 4
Porto Alegre 4
Reggio Calabria 4
Saint Petersburg 4
San José 4
Sassari 4
Serra 4
Stevenage 4
Verona 4
Volla 4
Totale 4.665
Nome #
Anticorpi anti-idiotipo 289
Primary versus systemic sclerosis-associated Raynaud’s phenomenon: relationship with clinical and environmental factors 229
Anticorpi monoclonali anti-idiotipo (Ab2) anti-CD4 inducono anticorpi anti-CD4 in un sistema singenico 229
Anticorpi anti-DNA e network idiotipico nel LES: recenti progressi e prospettive terapeutiche 179
Type II diabetes in systemic sclerosis patients: insights from an observational, multicenter study of GIRRCS (Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale) 168
Purificazione delle Immunoglobuline 150
Human CD4 "internal antigen" mimicry by anti-idiotypic monoclonal antibodies 134
Analisi della risposta immune indotta da anticorpi monoclonali murini anti-idiotipo (Ab2) anti-CD4 in un sistema xenogenico 131
Amyloidosis: clinical picture, immunological and biomolecular features, treatment prospects 130
A sandwich assay to detect and characterize syngeneic anti-idiotypic antibodies to murine anti-HLA and tumor associated antigen monoclonal antibodies 127
AB0171 Anti-carbamylated protein antibodies in patients with systemic sclerosis: an intriguing association with skin involvement 124
Preparation, characterization and utilization of monoclonal antibodies to the gene products of the HLA-D region with special emphasis on those to polymorphic determinants 122
Le vaccinazioni nei pazienti con immunodeficienza 121
Caratteristiche ed indicazioni terapeutiche dei preparati di immunoglobuline umane 120
SOLUBLE CD4 ANTIGEN REACTIVITY IN INTRAVENOUS IMMUNOGLOBULIN PREPARATIONS: IS IT SPECIFIC? 119
Anti-idiotypic monoclonal antibodies (mAb) to an anti-CD4 mAb induce CD4+ T cell depletion in rabbit 119
BETA-2 microglobulin (beta2m)-free HLA Class I heavy chain as prognostic marker of multiple myeloma 119
Anti-CD4 monoclonal antibody (mAb) and anti-idiotypic mAb to anti-CD4 in the therapy of autoimmune diseases 118
L'ospite immunocompromesso: un complesso sindromico in espansione. Quadri clinici, aspetti immunologici e prospettive terapeutiche 117
Purification of human immunoglobulins by sequential precipitation with caprylic acid and ammonium sulphate 116
Antiidiotypic monoclonal antibodies to anti HLA Class II monoclonal antibodies. Potential application in the treatment of autoimmune diseases 116
Uso di di un anticorpo monoclonale antiidiotipo di un anticorpo monoclonale anti-CD4 in pazienti con artrite reumatoide 116
Absence of streptococcal protein G (PG)-specific determinant in the Fab region of human IgG2 115
Cloning and chromosomal localization of a cDNA encoding a mitochondrial porin from Drosophila melanogaster 115
Studio funzionale e limiti terapeutici di anticorpi anti-idiotipo (Ab2) anti-CD4 nella infezione da HIV 115
ANTI-CARBAMYLATED PROTEIN ANTIBODIES IN PATIENTS WITH SYSTEMIC SCLEROSIS: AN INTRIGUING ASSOCIATION WITH SKIN INVOLVEMENT 114
Evaluation of the influence of social, demographic, environmental, work-related factors and/or lifestyle habits on Raynaud’s phenomenon: a case–control study 112
Analisi molecolare di un anticorpo monoclonale (ACMO) anti-idiotipo 'immagine interna' dell'antigene CD4 110
Mieloma multiplo e gammapatie monoclonali:quadri clinici, acquisizioni eziopatogenetiche e progressi terapeutici 109
Serum levels of beta2-microglobulin-free heavy chain of HLA class I antigen are increased in patients with multiple myeloma. Role of FHC size variant 107
Antiidiotype to anti-CD4 monoclonal antibody (mAb) as surrogate of human CD4 antigen (Ag) for active immunotherapy in autoimmune diseases 105
Human CD4 internal antigen anti-idiotypic monoclonal antibody. immunochemical and sequence analysis 104
Murine antiidiotypic monoclonal antibodies that bear the internal image of HLA-DR allospecificities 104
L'isoelettrofocalizzazione nello studio delle gammapatie monoclonali 104
CD4 mimicry by anti-idiotypic mAb (mAb2) F16-16D7 (16D7). Immunochemical and sequence analysis 103
BETA -MICROGLOBULIN-FREE HEAVY CHAIN FHC OF HLA CLASS I ANTIGEN IN PATIENTS WITH HODGKIN'S AND NON-HODGKIN'S LYMPHOMAS 102
Monoclonal antibodies in the immunotherapy of autoimmune diseases 100
Immunogenicity of 2 Idiotopes with A Different Immunoglobulin- Chain Distribution Expressed on the Same Anti-Cd4-Mab 99
L'AMILOIDOSI: QUADRI CLINICI, CARATTERISTICHE IMMUNOLOGICHE E BIOMOLECOLARI, PROSPETTIVE TERAPEUTICHE 99
Anti-idiotypic monoclonal antibodies reacting with idiotope on isolated- denatured chains of an anti-CD4 monoclonal antibody 99
Syngeneic antiidiotypic monoclonal antibodies to the murine anti-HLA- DR,DP monoclonal antibody CR11-462 97
Subclass and clonotypic profiles of serum AB elicited with the "human CD4 internal AG" mab F16-16D7 (16D7) in 4 patients with systemic lupus erythematosus 97
Evaluation of biotinylated cells as a source of antigens for characterization of their molecular profile 96
Syngeneic polyclonal and monoclonal antiidiotypic antibodies to murine anti HLA-B7,B27 monoclonal antibodies 96
Serological methods to detect anti-idiotypic antibodies 94
Fine specificity and idiotype diversity of the murine anti-HLA-A2, A28 monoclonal antibodies CR11-351 and KS1 93
Immunoterapia: realta' e fantasia 93
Minimum structural requirement for CD4 mimicry by anti-idiotipic mAb 16D7 93
Soluble CD4 and commercial immunoglobulin 93
Syngeneic anti-idiotypic antisera to murine anti-HLA class II monoclonal antibodies 91
Increased serum levels of beta2m-free HLA class I heavy chain in multiple myeloma 91
Purification of murine IgG monoclonal antibodies by precipitation with caprylic acid: comparison with other methods of purification 91
Vasculiti primarie sistemiche 90
Le gammapatie monoclonali: moderno inquadramento diagnostico e prognostico 89
The Fab region of IgG2 human myeloma proteins does not bear the streptococcal protein G-specific determinant 89
Human immunoglobulins in therapy. Rationale and clinical applications 89
Studi in vitro dell'attivita' antiallergica del Fenoterolo 89
Tailoring the treatment of inflammatory rheumatic diseases by a better stratification and characterization of the clinical patient heterogeneity. Findings from a systematic literature review and experts' consensus 88
La difesa immunologica contro i tumori: dalla teoria alla clinica 88
Immunochemical and functional characterization of anti-idiotypic antibodies to a mouse anti-CD4 monoclonal antibody 86
Le immunoglobuline in terapia: lo stato dell'arte 85
THU0164 Subclinical atherosclerosis and cardiovascular events in italian patients with rheumatoid arthritis: results from multicenter girrcs (gruppo italiano di ricerca in reumatologia clinica e sperimentale) study 81
Clinical and subclinical atherosclerosis in patients with systemic sclerosis: an observational, multicentre study of GIRRCS (Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale) 64
Occurrence and predictive factors of high blood pressure, type 2 diabetes, and metabolic syndrome in rheumatoid arthritis: Findings from a 3-year, multicentre, prospective, observational study 64
The negative impact of pain catastrophising on disease activity: analyses of data derived from patient-reported outcomes in psoriatic arthritis and axial spondyloarthritis 58
Novel biomarker for pulmonary vascular disease in systemic sclerosis patients 53
Dissecting the clinical heterogeneity of adult-onset Still's disease: Results from a multi-dimensional characterization and stratification 53
Pain catastrophizing and its domains significantly impact rheumatoid arthritis disease activity 51
Pain catastrophizing negatively impacts drug retention rate in patients with Psoriatic Arthritis and axial Spondyloarthritis: results from a 2-years perspective multicenter GIRRCS (Gruppo Italiano di Ricerca in Reumatologia Clinica) study 50
Parenchymal lung disease in adult onset Still's disease: An emergent marker of disease severity - Characterisation and predictive factors from Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale (GIRRCS) cohort of patients 49
Clinical correlates of a subset of anti-fibroblast antibodies in systemic sclerosis 42
Chronic-Relapsing cutaneous leukocytoclastic vasculitis in a young patient with reduced EBV-specific T cell response using enzyme-linked immunospot (ELISPOT) assay successfully treated with Valaciclovir 33
Totale 7.625
Categoria #
all - tutte 35.225
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 35.225


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022284 0 0 0 6 29 13 15 40 43 29 31 78
2022/20231.492 110 32 32 124 115 174 1 139 683 22 35 25
2023/2024207 33 17 19 19 29 34 1 22 0 5 2 26
2024/2025867 36 1 15 26 31 172 47 75 228 52 89 95
2025/20261.876 106 188 330 151 64 111 454 201 63 157 25 26
2026/2027515 23 193 127 172 0 0 0 0 0 0 0 0
Totale 7.625